Apr 19, 2022 | Newsletter 3 Research News
Return to newsletter Infants with more of the genetic differences related to autism were found to respond to faces differently, even at a very young age, before signs of autism might be noticeable. Many thanks to Birkbeck for allowing us to reprint this article about...
Apr 19, 2022 | Newsletter 3 Research News
Return to newsletter AIMS-2-TRIALS researchers are working alongside autistic people to develop technology that objectively measures aspects of their experience. Wearable devices, such as smart watches, can include sensors to record information like heart rate and...
Apr 19, 2022 | Newsletter 3 Research News
Innovation Radar is a European Commission initiative to identify innovations and innovators in EU-funded research. AIMS-2-TRIALS recently submitted several important developments to the scheme, receiving positive feedback and inclusion within the Innovation Radar...
Jan 27, 2022 | AIMS-2-TRIALS News
The Lancet has launched a first-of-its-kind Commission that “aims to answer the question of what can be done in the next 5 years to address the current needs of autistic individuals and families worldwide.” The Commission’s 32 representatives are co-led by Prof Tony...
Dec 14, 2021 | AIMS-2-TRIALS News
AIMS-2-TRIALS researchers have found that an infant’s ability to flexibly switch their gaze from one object to another (visual disengagement) differs based on their biological sex (male/female) and their socio-economic status (a measure of how income, education, and...
